Skip to content

MiNK Therapeutics, Inc.: filings

Every MiNK Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 202631920001193125-26-349309
10-Q2026-05-15fiscal Q1 202630650001193125-26-226804
10-K2026-03-31fiscal FY 202531640001193125-26-134813
10-Q2025-11-14fiscal Q3 202530930001193125-25-282905
10-Q2025-08-14fiscal Q2 202530900000950170-25-108894
10-Q2025-05-15fiscal Q1 202530630000950170-25-072789
10-K2025-03-18fiscal FY 202435700000950170-25-041379
10-Q2024-11-14fiscal Q3 202432930000950170-24-127033
10-Q2024-08-13fiscal Q2 202432880000950170-24-096142
10-Q2024-05-14fiscal Q1 202431640000950170-24-059081
10-K2024-03-21fiscal FY 202334700000950170-24-034672
10-Q2023-11-14fiscal Q3 202332960000950170-23-063851
10-Q2023-08-10fiscal Q2 202332900000950170-23-040958
10-Q2023-05-11fiscal Q1 202332650000950170-23-021191
10-K2023-03-24fiscal FY 202234680000950170-23-009762
10-Q2022-11-03fiscal Q3 202232940000950170-22-021565
10-Q2022-08-15fiscal Q2 202231890001564590-22-029503
10-Q2022-05-13fiscal Q1 202228570001564590-22-020146
10-K2022-03-18fiscal FY 202128570001564590-22-011026
10-Q2021-11-29fiscal Q3 202127800001564590-21-058700

Inspect the source

Entity
MiNK Therapeutics, Inc. / CIK 0001840229
Captured
2026-09-21T17:29:59.682Z
SEC response SHA-256
379e7984f39fecf40700776a838a67706b02060bd609a2e40e4f28d70bf01adb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001840229.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))